Centre of Excellence in Nutraceuticals inaugurated by the Hon’ble Chief Minister of Kerala

T’puram: Chief minister Pinarayi Vijayan virtually inaugurated a centre of excellence in nutraceuticals (CoEN) at Bio 360 Life Sciences Park, Thonnakkal, on Monday.

The initiative, spearheaded by Kerala State Council for Science, Technology and Environment (KSCSTE), with support from Kerala Development and Innovation Strategic Council (K-DISC) and Kerala State Industrial Development Corporation (KSIDC) and financial assistance from KIIFB, aims to position state as a leading hub for research and innovation in the rapidly expanding nutraceutical sector.

In his address, Vijayan highlighted the growing global relevance of nutraceuticals in addressing modern health challenges. “Bioactive compounds derived from food play an important role in enhancing immunity, preventing diseases and managing chronic conditions. The establishment of a centre of excellence in nutraceuticals marks a significant milestone in Kerala’s efforts to advance science-based preventive healthcare,” he said.

The centre began functioning at the campus of Institute of Advanced Virology (IAV) within Bio 360 Life Sciences Park and was allotted 5 acres for developing its dedicated infrastructure. The project will be implemented in phases, with Rs 13.99 crore sanctioned by KIIFB over a 5-year period.

Presenting the institutional roadmap, E Sreekumar, chief executive officer of CoEN, said Phase 1 will focus on research, technology development and scientific validation of nutraceutical formulations, particularly in areas related to metabolic health and wellness. Phase 2 will establish an enterprise division to facilitate manufacturing, technology transfer and commercialisation of research outcomes in collaboration with industry.

In the keynote address, C Anantharamakrishnan, director of CSIR–NIIST, hailed Kerala govt for its proactive initiatives in promoting science, research and innovation, noting that such efforts are crucial for strengthening the state’s emerging bioeconomy and nutraceutical sector.

Related Posts

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharmaceutical Industries Ltd has announced that it has entered into a definitive agreement under which it will acquire all outstanding shares of Organon for $14.00 per share in an…

HP accounts for 47 inferior drugs in March alert

Kullu: In an alert issued for the month of March, the Central Drugs Standard Control Organisation (CDSCO) has declared a total of 141 drugs to be of substandard quality. Out…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert

Civil society group SAM calls for greater transparency involving clinical trials

Civil society group SAM calls for greater transparency involving clinical trials

Different packaging, typos expose fake Mounjaro racket

Different packaging, typos expose fake Mounjaro racket

To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore